Literature DB >> 3380231

Central pontine and extrapontine myelinolysis following correction of severe hyponatremia.

R Peces1, P Ablanedo, J Alvarez.   

Abstract

A chronically hyponatremic patient developed neurological features of pontine level disconnection following the raising of serum sodium. At autopsy histopathological examination confirmed the presence of myelinolysis in the central pons and similar symmetrical lesions in the thalamus. In chronic hyponatremic patients, more than the rapidity of correction, the magnitude of the osmolar change may predispose to development of these lesions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380231     DOI: 10.1159/000185044

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

Review 1.  How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.

Authors:  Javier A Neyra; Lenar Yessayan; Melissa L Thompson Bastin; Keith M Wille; Ashita J Tolwani
Journal:  Kidney360       Date:  2020-12-14

Review 2.  Symptomatic hyponatraemia: can myelinolysis be prevented by treatment?

Authors:  C P Harris; J J Townsend; J R Baringer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

3.  A case of mistaken identity: alcohol withdrawal, schizophrenia, or central pontine myelinolysis?

Authors:  Paul Schneider; Vicki A Nejtek; Cheryl L Hurd
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-01       Impact factor: 2.570

Review 4.  Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia.

Authors:  Markus Pirklbauer
Journal:  Hemodial Int       Date:  2020-05-20       Impact factor: 1.812

5.  Uremia Preventing Osmotic Demyelination Syndrome Despite Rapid Hyponatremia Correction.

Authors:  Srinadh Annangi; Snigdha Nutalapati; Srikanth Naramala; Pradeep Yarra; Khalid Bashir
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.